Budget 2025: Tax cuts, sops on Pharma Inc’s wish list

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax exemptions on life-saving drugs in the upcoming Union budget. They want more oncology drugs to be tax-exempt and lower customs duties on essential medical equipment.…

Read More

Only vishwas, no vivad: Just 1% of ITRs face scrutiny

Even the minuscule 1% cases picked for scrutiny are based on credible information available with the department through third-party reporting, they said, pushing back against the criticism of aggressive income assessment notices. The scrutiny happens only in those cases flagged…

Read More